Key result
Respiratory and other infectious diseases drive significant athlete morbidity and require careful return-to-play management.
Why the study?
Infectious diseases cause significant morbidity in athletes and present unique challenges in treatment, prevention, and return to play considerations.
Infectious diseases cause significant morbidity in athletes, requiring careful management of treatment, prevention, and return-to-play protocols.
May warrant enhanced infection protocols in athletes; leaves open optimal return-to-play criteria pending prospective trials.
While orthopedic injuries most commonly are associated with sports, infectious diseases cause significant morbidity in athletes. Exercise improves immunity at moderate intensity but impairs immune function at extremes of duration and intensity. Respiratory infections are the most common, but skin, blood borne, sexually transmitted, and even cardiac infections occur. Infectious disease outbreaks are a constant concern. Treatment of such infections resembles those used in the general population. Return to play issues and prevention of infection are especially important in athletes.
No takes yet. Share an insight, caveat, or question.
Mark D. Harris (2011) conducted a review in Infectious diseases in athletes. Infectious diseases, particularly respiratory infections, cause significant morbidity in athletes and require careful management for prevention and return to play.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: